Maternal serum free-β-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13+6 weeks in relation to co-variables in pregnant Saudi women

被引:18
作者
Ardawi, Mohammed-Salleh M.
Nasrat, Hasan A.
Rouzi, Abdulrahim A.
Qari, Mohammed H.
Al-Qahtani, Mohammed H.
Abuzenadah, Adel M.
机构
[1] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah 21465, Saudi Arabia
[2] King Abdulaziz Univ Hosp, Jeddah 21465, Saudi Arabia
[3] King Abdulaziz Univ, Fac Appl Med Sci, Dept Med Technol, Jeddah 21465, Saudi Arabia
[4] King Abdulaziz Univ, Genom Med Unit, Jeddah 21465, Saudi Arabia
关键词
first trimester; fetal nuchal translucency; maternal serum screening; co-variables;
D O I
10.1002/pd.1661
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Objective To establish normative values and distribution parameters of first-trimester screening markers, namely, fetal nuchal translucency (NT), maternal serum free beta-human chorionic gonadotrophin (beta-hCG) and pregnancy-associated plasma protein-A (PAPP-A), at 10 to 13(+6) weeks of gestation in Saudi women and to evaluate the effect of co-variables including maternal body weight, gravidity, parity, fetal gender, twin pregnancy, smoking and ethnicity on these markers. Methods A cohort of Saudi women (first cohort n = 1616) with singleton pregnancies prospectively participated in the present study, and fetal NT together with maternal serum free beta-hCG and PAPP-A were determined at 10 to 13(+6) weeks of gestation. The distribution of gestational age-independent multiples of the median (MoM) of the parameters was defined and normative values were established, and correction for maternal body weight was made accordingly. The influence of various co-variables was examined using the data collected from the first and the second (n = 1849) cohorts of women and 62 twin pregnancies, and compared with other studies. Results All markers exhibited log-normally distributed MoMs. Gestational age-independent normative values were established. Maternal body weight was corrected, particularly for maternal free beta-hCG and PAPP-A using standard methods. Fetal NT showed a negative relationship with increasing gravidity (r = -0.296) or parity (r = -0.311), whereas both free beta-hCG and PAPP-A exhibited a significant positive relationship. There was a significant increase in the MoM of free beta-hCG in female fetuses. Smoking decreased MoM values of free beta-hCG (by 14.6%; P < 0.01) and PAPP-A (by 18.8%; P < 0.001). Twin pregnancy showed significant increases in MoM values of free beta-hCG (by 1.87-fold) and PAPP-A (by 2.24-fold), with no significant changes in fetal NT MoM values. Fetal NT MoM values were lower in Africans and Asians but higher in Orientals, as compared to Saudi women (P < 0.05; in each case). MoM values (body weight-corrected) of free beta-hCG were 25.2% higher in Africans and 19.4% higher in Orientals but 6.8% lower in other Arabian and Asian (by 5.8%) women as compared to Saudi women (P < 0.05; in each case). Conclusions The normative values and distribution parameters for fetal NT, maternal serum free beta-hCG and PAPP-A were established in Saudi singleton pregnancies, the maternal body weight together with smoking, twin pregnancy and ethnicity being important first-trimester screening co-variables. Gravidity, parity and fetal gender are also considered to influence one or more of the first-trimester markers examined. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:303 / 311
页数:9
相关论文
共 84 条
[21]   Gender impact on first trimester markers in Down syndrome screening [J].
Larsen, SO ;
Wojdemann, KR ;
Shalmi, AC ;
Sundberg, K ;
Christiansen, M ;
Tabor, A .
PRENATAL DIAGNOSIS, 2002, 22 (13) :1207-1208
[22]   Higher median levels of free β-hCG and PAPP-A in the first trimester of pregnancy in a Chinese ethnic group [J].
Leung, TY ;
Spencer, K ;
Leung, TN ;
Fung, TY ;
Lau, TK .
FETAL DIAGNOSIS AND THERAPY, 2006, 21 (01) :140-143
[23]   First-trimester or second-trimester screening, or both, for Down's syndrome [J].
Malone, FD ;
Canick, JA ;
Ball, RH ;
Nyberg, DA ;
Comstock, CH ;
Bukowski, R ;
Berkowitz, RL ;
Gross, SJ ;
Dugoff, L ;
Craigo, SD ;
Timor-Tritsch, IE ;
Carr, SR ;
Wolfe, HM ;
Dukes, K ;
Bianchi, DW ;
Rudnicka, AR ;
Hackshaw, AK ;
Lambert-Messerlian, G ;
Wald, NJ ;
D'Alton, ME .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (19) :2001-2011
[24]   A morphometric study of maternal smoking on apoptosis in the syncytiotrophoblast [J].
Marana, HRC ;
Andrade, JM ;
Martins, GA ;
Silva, JS ;
Sala, MA ;
Cunha, SP .
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 1998, 61 (01) :21-27
[25]   A comparison between maternal serum free β-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies [J].
Mashiach, R ;
Orr-Urtreger, A ;
Yaron, Y .
FETAL DIAGNOSIS AND THERAPY, 2004, 19 (02) :174-177
[26]   Current concepts of Down syndrome screening tests in assisted reproduction twin pregnancies: another double trouble [J].
Maymon, R ;
Neeman, O ;
Shulman, A ;
Rosen, H ;
Herman, A .
PRENATAL DIAGNOSIS, 2005, 25 (09) :746-750
[27]   Nuchal translucency measurement and pregnancy outcome after assisted conception versus spontaneously conceived twins [J].
Maymon, R ;
Jauniaux, E ;
Holmes, A ;
Wiener, YM ;
Dreazen, E ;
Herman, A .
HUMAN REPRODUCTION, 2001, 16 (09) :1999-2004
[28]  
Neveux LM, 1996, PRENATAL DIAG, V16, P1115, DOI 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO
[29]  
2-6
[30]   Nuchal translucency and other first-trimester sonographic markers of chromosomal abnormalities [J].
Nicolaides, KH .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (01) :45-67